Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05481723Phase 3Recruiting
Phase 3, randomised, open-label trial (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Number of Postoperative Organ failure at 7 days. Started Jul 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05481723.